Testosterone replacement in men with T2DM lowers HbA1c: ABCD worldwide audit

madman

Super Moderator


At EASD 2023 in Hamburg, Professor Hugh Jones presents an analysis from the ABCD audit of Testosterone in Men with Type 2 Diabetes, confirming that testosterone replacement therapy does improve glycaemic control. Furthermore, the data showed that HbA1c continues to decrease over time. This was likely to be due to the ongoing effect of testosterone on fat reduction.
 
Screenshot (32003).webp

Screenshot (32006).png
 
 

ExcelMale Newsletter Signup

Online statistics

Members online
5
Guests online
323
Total visitors
328

Latest posts

Beyond Testosterone Podcast

Back
Top